News | RIVM

SARS-CoV-2 infections continue to rise

Infections with the coronavirus SARS-CoV-2 in the Netherlands continued to rise this week. This increase can be seen in sewage surveillance and in the infections reported to the Municipal Public Health Services (GGDs).

Upward trend in infections continues

Infections with the coronavirus SARS-CoV-2 in the Netherlands have increased for the third week in a row. The number of patients admitted to hospital nursing wards remained the same this week.

COVID-19 vaccination figures more up-to-date due to optimised monitoring

RIVM has been publishing national and regional figures on COVID-19 vaccination in the Netherlands every week since 19 January 2021.

Even after COVID-19 crisis, social isolation continues

Even after most coronavirus measures have been discontinued, some people are still living in social isolation to avoid COVID-19 exposure.

People with impaired immunity invited for repeat vaccination

From 19 April on, people who have moderately or severely impaired immunity will receive their invitation for a repeat vaccination against COVID-19.

RIVM recalls fill needles for COVID-19 vaccination at supplier’s request

As of today, RIVM is recalling the fill needles made by MLS/Sol-Millenium Europe as a precaution, following a safety alert from the supplier. This applies to the SOL-M™ Blunt Fill Needle (REF 110022, LOT 05103013).

Bakje met optreknaalden coronavaccinatie

Repeat vaccination against COVID-19 now also available for over-60s

People aged 60 to 69 years (and people who turn 60 this year) will also have the opportunity to make an appointment for an extra COVID-19 vaccination. Minister Kuipers decided this based on advice from the Health Council of the Netherlands.

60-plusser krijgt herhaalprik tegen corona (2de boosterprik)

Janssen booster possible as of 25 March

People in the Netherlands who cannot get a booster with an mRNA vaccine for medical reasons, or do not want an mRNA vaccine as a booster, can make an appointment for a booster vaccination with Janssen from Wednesday 23 March on.

Protection from COVID-19 booster wanes slightly after 3 months among over-70s

In the period from 1 February to 8 March 2022, the first indications were observed that protection against hospital admission after COVID-19 booster vaccination decreases over time in people over 7

Novavax vaccine available

The Novavax vaccine is a protein-based vaccine which can offer an alternative for people who are hesitant about immunisation with an mRNA vaccine or vector vaccine, or for people who have a contraindication for mRNA vaccines.